The National Vaccine Injury Compensation Program was established in the late 1980s after lawsuits related to the older DTP vaccine led several manufacturers to leave the market and contributed to vaccine shortages, prompting Congress to enact measures that partially shielded vaccine manufacturers from liability to help ensure continued vaccine production.
high
historical
Explains the legislative and market context that led to creation of the compensation program.